Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guaifenesin and Hydrocodone Interaction Study
NCT03642873Phase 1Completed
- Sponsor
- Reckitt
- Start
- May 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of guaifenesin in cough (3 arms), sponsored by Reckitt. Primary endpoints: Maximum Observed Plasma Concentration of Guaifenesin, Area Under Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration of Guaifenesin and 4 more. Started May 2007; status: completed.
02
Drugs
guaifenesin
03
Conditions
cough
Beyond the preview
Go deeper on NCT03642873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642873.